Friday 20 November 2009, 12:00AM
PEARLS No. 206, October 2009, written by Brian R McAvoy -
download pdf
Clinical question
How effective is garlic for the prevention or treatment of the
common cold?
Bottom line
There is no conclusive evidence to recommend garlic supplements
as a preventative or treatment option for the common cold. A
single, small trial suggested garlic might reduce the frequency of
symptoms of the common cold if taken continuously as a daily
prophylactic but the results require validation. On average
individuals taking garlic had colds lasting 1.52 days while those
taking a placebo had colds lasting 5.01 days. There is currently no
evidence to help decide whether treating common colds with garlic
will reduce symptom severity or days of illness. Anecdotally,
adverse events reported include odour, and minor skin or
respiratory irritation. The frequency of adverse effects could not
be determined from the evidence available.
Caveat
Only one trial that met the selection criteria was identified,
limiting the conclusions that can be drawn. Inclusion and exclusion
criteria were not reported, nor were differences in comorbidity or
concurrent illnesses. These factors reduce the generalisability of
the trial and may have introduced bias into the results. No trial
was identified that looked at whether taking garlic for symptoms of
the cold reduces its severity or duration. However, in the included
study, the number of days to recover from a cold was similar for
both groups.
Context
Garlic is alleged to have antimicrobial and antiviral properties
that relieve the common cold, among other beneficial effects. There
is widespread usage of garlic supplements. The common cold is
associated with significant morbidity and economic consequences. On
average, children have 6 to 8 colds per year, and adults have 2 to
4.
Cochrane Systematic Review
Lissiman E et al. Garlic for the common cold. Cochrane Reviews
2009, Issue 3. Article No. CD006206. DOI: 10.1002/14651858.
CD006206.pub2. This review contains one study involving 146
participants.